Dr Philip Camilleri: Clinical oncology
Search
Search for Bupa recognised healthcare professionals and facilities.
+ any details

Dr Philip Camilleri

Clinical oncology

 

  • Fee assured
Overview

Specialises in

  • Urology

About me

Dr Philip Camilleri was appointed as Consultant Clinical Oncologist in 2006 having trained in Clinical Oncology in Oxford
Dr Camilleri currently specialises in urological cancers, specifically prostate, bladder, testicular cancers. He provides chemotherapy, hormonal as well as radiotherapy treatment.
Dr Camilleri delivers prostate brachytherapy at the Oxford Cancer Centre. He also provides Intensity Modulated Radiotherapy (IMRT) with Image guidance (IGRT) for prostate cancers. He is involved in research for most urological cancers.

Areas of interest

Prostate disease including prostate cancer; Testicular cancer; Bladder cancer; Urological oncology treating with IMRT, IGRT and brachytherapy; Chemotherapy including docetaxel and cabazitaxel; Hormone therapy including abiraterone (zytiga) and enzalutamide (xtandi); Bone therapy with zometa and denosumab; Radium 223 therapy (xofigo)

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • AA844

    Clinical supervision and planning for delivery of chemotherapy cycle in the member's home 1-28 days - (5-50)

  • X0008

    Clinical supervision of external beam radiotherapy, for 16 or up to and including 30 fractions - (5-50)

  • X6581

    Clinical supervision of the delivery of a single fraction of radiotherapy - (5-50)

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (5-50)

  • X6774

    Preparation for intermediate radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)

  • X6910

    Clinical supervision of the planning of a course of simple radiotherapy - (1-5)

  • BT211

    Planning for insertion and removal of a radioactive agent (brachytherapy) into prostate tumour - (1-5)

  • Show All (10)...
Edit details Print page

The information contained on Finder is submitted by consultants, therapists and facilities, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the data and information on Finder and our website terms of use here.